We are live on ! Find out more
MNOV icon

MediciNova
MNOV

41 hedge funds and large institutions have $12.6M invested in MediciNova in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

17% more funds holding

Funds holding: 35 → 41 (+6)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1.3% less ownership

Funds ownership: 13.96% → 12.66% (-1.3%)

15% less capital invested

Capital invested by funds: $14.9M → $12.6M (-$2.28M)

25% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 12

Holders
41
Holders Change
+6
Holders Change %
+17.14%
% of All Funds
0.66%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
9
Reduced
12
Closed
4
Calls
$33K
Puts
–
Net Calls
+$33K
Net Calls Change
+$28K

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$592K
2
HF
HRT Financial
New York
+$396K
3
E
Ergoteles
New York
+$245K
4
CFM
Capricorn Fund Managers
United Kingdom
+$147K
5
Goldman Sachs
Goldman Sachs
New York
+$113K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$2.65M
2
Millennium Management
Millennium Management
New York
-$224K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$108K
4
JP Morgan Chase
JP Morgan Chase
New York
-$108K
5
UBS Group
UBS Group
Switzerland
-$65.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
ECM
26
ExodusPoint Capital Management
New York
$48K +$51.2K +23,184 New
Morgan Stanley
27
Morgan Stanley
New York
$46.2K +$24K +10,852 +93%
T. Rowe Price Associates
28
T. Rowe Price Associates
Maryland
$42K – – –
Bank Julius Baer & Co
29
Bank Julius Baer & Co
Switzerland
$39K +$663 +300 +2%
Squarepoint
30
Squarepoint
New York
$38.4K +$41.4K +18,744 New
Charles Schwab
31
Charles Schwab
California
$36.6K – – –
BF
32
Blankinship & Foster
California
$32.2K – – –
WA
33
WealthTrust Axiom
Pennsylvania
$25.6K – – –
CSS
34
Cubist Systematic Strategies
Connecticut
$21.6K +$23.3K +10,528 New
Qube Research & Technologies (QRT)
35
Qube Research & Technologies (QRT)
United Kingdom
$21.4K -$54.4K -24,626 -70%
CG
36
Cutler Group
California
$4K – – –
BNP Paribas Financial Markets
37
BNP Paribas Financial Markets
France
$845 – – –
Wells Fargo
38
Wells Fargo
California
$685 +$18 +8 +2%
Northwestern Mutual Wealth Management
39
Northwestern Mutual Wealth Management
Wisconsin
$625 – – –
Dimensional Fund Advisors
40
Dimensional Fund Advisors
Texas
$153 +$63.8K +28,906 +63%
Ameriprise
41
Ameriprise
Minnesota
– -$42K -19,300 Closed
FPAS
42
Focus Partners Advisor Solutions
Missouri
– -$22K -10,000 Closed
CS
43
Credit Suisse
Switzerland
– -$3K -1,200 Closed
NA
44
NewEdge Advisors
Louisiana
– +$18 +8 New
1
2

MNOV Hedge Fund Activity: Q4 2022 in Review

41 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q4 2022, worth a combined $12.6M — down 15% from $14.9M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new MNOV positions and 4 closed out — a net gain of 6 holders — while 9 added to existing stakes and 12 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $592K. The largest seller was Vanguard Group, cutting an estimated $2.65M.

  • 41 institutional investors held MediciNova (MNOV) as of Q4 2022, up from 35 in Q3 2022.
  • Funds reported $12.6M of MediciNova stock for Q4 2022, down 15% quarter-over-quarter.
  • 10 funds opened new MediciNova positions in Q4 2022 and 4 closed out, a net change of +6 holders.
  • The largest MediciNova buyer in Q4 2022 was Jane Street, an estimated $592K added.
  • The largest MediciNova seller in Q4 2022 was Vanguard Group, an estimated $2.65M sold.

Based on aggregated 13F filings for Q4 2022.